Journals / Haseki Tıp Bülteni / 2010 / Cilt: 48 - Sayı: 3

Encapsulating peritoneal sclerosis and its treatment

Enkapsül,ze periton sklerozu ve tedavisi

Pages
95–98
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the last few years, the mortality has decreased to a few percentage points as a result of the advances in the surgical techniques, but the recurrence rate is still very high. (The Medical Bulletin of Haseki 2010; 48: 95-8)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Encapsulating peritoneal sclerosis is a rare but serious complication of peritoneal dialysis.
📊
Key Findings & Data:The patients at high risk include those on peritoneal dialysis for more than 8-10 years and with high peritoneal transport characteristics, as well as those with a history of frequent peritonitis.
💡
Conclusion & Impact:In the last few years, the mortality has decreased to a few percentage points as a result of the advances in the surgical techniques, but the recurrence rate is still very high. (The Medical Bulletin of Haseki 2010; 48: 95-8)
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Encapsulating peritoneal sclerosis is a rare but serious complication of peritoneal dialysis. The patients at high risk include those on peritoneal dialysis for more than 8-10 years and with high peritoneal transport characteristics, as well as those with a history of frequent peritonitis. Effective medical treatment with tamoxifen and immunosuppressive agents has been reported. Surgical enterolysis is necessary when irreversible intestinal obstruction develops. In the last few years, the mortality has decreased to a few percentage points as a result of the advances in the surgical techniques, but the recurrence rate is still very high. (The Medical Bulletin of Haseki 2010; 48: 95-8)

Özet

Periton diyalizinin nadir görülen ancak çok ciddi bir komplikasyonu olan enkapsülize periton sklerozu en az sekiz-on yıldır periton diyalizi yapan hastalarda ortaya çıkabilir. Tekrarlayan peritonit atakları olan ve periton geçirgenliği yüksek bulunan hastalarda enkapsülize periton sklerozu riski artmıştır. Tamoksifen ve immünsupresif ilaçlarla etkin tedavi yapılabildiği gösterilmiştir. Barsak tıkanıklığı geliştiğinde cerrahi girişim yapılarak enterolizis gerçekleştirilir. Son yıllarda cerrahi girişim sonrası mortalite azaltılmakla beraber periton sklerozu rekürrensi halen yüksek sıklıktadır. (Haseki Tıp Bülteni 2010; 48: 95-8)

🔖

Cite This Article

KAZANCIOĞLU, R. (2010). Encapsulating peritoneal sclerosis and its treatment. Haseki Tıp Bülteni, Cilt: 48 - Sayı: 3, 95–98. https://ajindex.com/articles/268259

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Gandhi VC, Humayun HM, Ing TS, et al. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980;140:1201-3
  2. Guest S. Hypothesis: gender and encapsulating peritoneal sclerosis. Perit Dial Int 2009;29:489-91
  3. Guest S. Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experience. Perit Dial Int 2009;29:252-5
  4. Nakamoto H. Encapsulating peritoneal sclerosis-a clinician’s approach to diagnosis and medical treatment. Perit Dial Int 2005;25:30-8
  5. Lo WK, Kawanishi H. Encapsulating peritoneal sclerosis-medical and surgical treatment. Perit Dial Int 2009;29:211-4
  6. Balasubramaniam G, Brown EA, Davenport A, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2009:24:3209-15
  7. Fieren MWJA, Betjes MGH, Korte MR, Boer WH. Posttransplant encapsulating peritoneal sclerosis: a worrying new trend. Perit Dial Int 2007;27:619-24
  8. Saito A. Peritoneal dialysis in Japan: the issue of encapsulating peritoneal sclerosis and future challenges. Perit Dial Int 2005;25:77-82
  9. Hoshii S, Honda M. High incidence of encapsulating peritoneal sclerosis in pediatric patients on peritoneal dialysis longer than 10 years. Perit Dial Int 2002;22:730-1
  10. Kawanishi H, Moriishi M. Encapsulating peritoneal sclerosis: prevention and treatment. Perit Dial Int 2007;27:289-92
  11. Evrenkaya TR, Atasoyu EM, Unver S, Basekim C, Baloglu H, Tulbek MY. Corticosteroid and tamoxifen therapy in sclerosing encapsulating peritonitis in a patient on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2004;19:2423-4
  12. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000;20:43-55
  13. Augustine T, Brown PW, Davies SD, Summers AM, Wilkie ME. Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin Pract 2009;111:149-54
  14. Yılmaz R, Arıcı M. Periton diyalizinin uzun dönem komplikasyonları. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 2007;16:62-7
  15. Hür E, Bozkurt D, Nar H, et al. Renin anjiyotensin sistemi inhibisyonu enkapsüle periton sklerozu gelişmesini engelleyebilir. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi 2009;18:112-6. 1